Simple drug may cut blood loss in breast surgery
NCT ID NCT05945680
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a single dose of tranexamic acid, given before surgery, can reduce blood loss in women undergoing breast cosmetic surgery. 60 women participated, and researchers measured blood loss, hemoglobin, and other clotting factors. The goal is to see if this common drug can make these procedures safer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- tranexamic acid
- What this could lead to
- If it works, this could offer a simple way to reduce bleeding during breast cosmetic surgery, potentially improving recovery.
- What could go wrong
- This is a small, completed phase 4 trial with only 60 participants. Results may not apply to all patients, and tranexamic acid carries a risk of blood clots.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLEEDING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Poznan University of Medical Sciences
Poznan, Poland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new dissolvable dressing stop surgical bleeding faster?
- Can early blood transfusions save more trauma victims?
- Medical glue vs. internal bleeding: a new hope?
- Can a single stitch beat a double closure for TAVI patients?
- A cup of lavender tea a day may keep PMS blues away — science puts it to the test
- A facelift without the bruising? tranexamic acid put to the test.